Granite Investment Partners, LLC Ionis Pharmaceuticals Inc Transaction History
Granite Investment Partners, LLC
- $2.26 Billion
- Q3 2024
A detailed history of Granite Investment Partners, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Granite Investment Partners, LLC holds 85,793 shares of IONS stock, worth $2.92 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
85,793
Previous 114,090
24.8%
Holding current value
$2.92 Million
Previous $5.44 Million
36.8%
% of portfolio
0.15%
Previous 0.23%
Shares
4 transactions
Others Institutions Holding IONS
# of Institutions
402Shares Held
136MCall Options Held
862KPut Options Held
582K-
Vanguard Group Inc Valley Forge, PA15.1MShares$512 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$482 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$351 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.74MShares$297 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$268 Million5.32% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.83B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...